Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.
2.

[SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].

Tandt H, Audenaert K, van Heeringen C.

Tijdschr Psychiatr. 2009;51(6):387-93. Review. Dutch.

3.

Risk of suicide in depression and its implication for psychopharmacological treatment.

Kasper S, Schindler S, Neumeister A.

Int Clin Psychopharmacol. 1996 Jun;11(2):71-9. Review.

PMID:
8803644
4.

Pharmacotherapy of major depressive disorder in adolescents.

Masi G, Liboni F, Brovedani P.

Expert Opin Pharmacother. 2010 Feb;11(3):375-86. doi: 10.1517/14656560903527226. Review.

PMID:
20102303
5.

Are adolescents dying by suicide taking SSRI antidepressants? A review of observational studies.

Dudley M, Goldney R, Hadzi-Pavlovic D.

Australas Psychiatry. 2010 Jun;18(3):242-5. doi: 10.3109/10398561003681319. Review.

PMID:
20482427
7.

Antidepressants and suicidal risk.

Müller-Oerlinghausen B, Berghöfer A.

J Clin Psychiatry. 1999;60 Suppl 2:94-9; discussion 111-6. Review.

8.

Pharmacological treatment of major depressive disorder in adolescents.

Farley RL.

ScientificWorldJournal. 2005 May 13;5:420-6. Review.

9.

How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?

Hall WD, Lucke J.

Aust N Z J Psychiatry. 2006 Nov-Dec;40(11-12):941-50. Review.

PMID:
17054562
10.

Risk of suicidality in depression with serotonergic antidepressants.

Matthews JD, Fava M.

Ann Clin Psychiatry. 2000 Mar;12(1):43-50. Review.

PMID:
10798825
11.

Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.

Ruhé HG, Huyser J, Swinkels JA, Schene AH.

J Clin Psychiatry. 2006 Dec;67(12):1836-55. Review.

PMID:
17194261
12.

Antidepressants and suicide risk: issues of chemical and behavioral toxicity.

Molcho A, Stanley M.

J Clin Psychopharmacol. 1992 Apr;12(2 Suppl):13S-18S. Review.

PMID:
1577985
13.

Suicide prevention and serotonergic drugs.

Montgomery SA.

Int Clin Psychopharmacol. 1993 Nov;8 Suppl 2:83-5. Review.

PMID:
8201249
14.

[Selective serotonin reuptake inhibitors and depression in the child and adolescent].

Condat A, Mouren-Simeoni MC.

Encephale. 2000 May-Jun;26(3):53-60. Review. French.

PMID:
10951906
15.

Screening for child and adolescent depression in primary care settings: a systematic evidence review for the US Preventive Services Task Force.

Williams SB, O'Connor EA, Eder M, Whitlock EP.

Pediatrics. 2009 Apr;123(4):e716-35. doi: 10.1542/peds.2008-2415. Review.

PMID:
19336361
16.

ACNP Task Force report on SSRIs and suicidal behavior in youth.

Mann JJ, Emslie G, Baldessarini RJ, Beardslee W, Fawcett JA, Goodwin FK, Leon AC, Meltzer HY, Ryan ND, Shaffer D, Wagner KD.

Neuropsychopharmacology. 2006 Mar;31(3):473-92. Review.

17.

Newer antidepressants. Beyond selective serotonin reuptake inhibitor antidepressants.

McConville BJ, Chaney RO, Browne KL, Friedman L, Cottingham E, Nelson D.

Pediatr Clin North Am. 1998 Oct;45(5):1157-71. Review.

PMID:
9884680
18.

[Antidepressants and suicide in adolescents].

Silva M, Sampaio D.

Acta Med Port. 2011 Jul-Aug;24(4):603-12. Epub 2011 Dec 12. Review. Portuguese.

19.

Selective serotonin reuptake inhibitors and violence: a review of the available evidence.

Walsh MT, Dinan TG.

Acta Psychiatr Scand. 2001 Aug;104(2):84-91. Review.

PMID:
11473500
20.

Modern bioanalytical methods for the rapid detection of antidepressants: SNRIs and SSRIs in human biological samples.

Samanidou V, Kourti P.

Bioanalysis. 2009 May;1(2):451-88. doi: 10.4155/bio.09.38. Review.

PMID:
21083177

Supplemental Content

Support Center